©The Author(s) 2024.
World J Virol. Mar 25, 2024; 13(1): 89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Table 3 Patient demographics of the occult hepatitis B infection group
| Patient demographics | No. of patients | Percentage | |
| Age | 52 yr | 1 | 33.3 |
| 75 yr | 1 | 33.3 | |
| 78 yr | 1 | 33.3 | |
| Sex | Female | 1 | 33.3 |
| Male | 2 | 66.7 | |
| Malignancy | AML | 1 | 33.3 |
| Colon | 1 | 33.3 | |
| NSGCT | 1 | 33.3 | |
| USG | Normal | 1 | 33.3 |
| Coarse liver | 2 | 66.7 | |
| History of Jaundice | Yes | 2 | 66.7 |
| No | 1 | 33.3 | |
| History of blood transfusion in the past | Yes | 1 | 33.3 |
| No | 2 | 66.7 | |
| History of surgery in the past | Yes | 1 | 33.3 |
| No | 2 | 66.7 | |
| Family history | Yes | 0 | 0.0 |
| No | 3 | 100.0 | |
- Citation: Sudevan N, Manrai M, Tilak TVSVGK, Khurana H, Premdeep H. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study. World J Virol 2024; 13(1): 89104
- URL: https://www.wjgnet.com/2220-3249/full/v13/i1/89104.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i1.89104